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ABSTRACT
The TATA binding protein (TBP) plays a pivotal role
in RNA polymerase II (Pol II) transcription through
incorporation into the TFIID and B-TFIID complexes.
The role of mammalian B-TFIID composed of TBP
and B-TAF1 is poorly understood. Using a com-
plementation system in genetically modified mouse
cells where endogenous TBP can be condi-
tionally inactivated and replaced by exogenous
mutant TBP coupled to tandem affinity purification
and mass spectrometry, we identify two TBP
mutations, R188E and K243E, that disrupt the TBP–
BTAF1 interaction and B-TFIID complex formation.
Transcriptome and ChIP-seq analyses show that
loss of B-TFIID does not generally alter gene ex-
pression or genomic distribution of TBP, but posi-
tively or negatively affects TBP and/or Pol II
recruitment to a subset of promoters. We identify
promoters where wild-type TBP assembles a
partial inactive preinitiation complex comprising
B-TFIID, TFIIB and Mediator complex, but lacking
TFIID, TFIIE and Pol II. Exchange of B-TFIID in
wild-type cells for TFIID in R188E and K243E
mutant cells at these primed promoters completes
preinitiation complex formation and recruits Pol II to
activate their expression. We propose a novel regu-
latory mechanism involving formation of a partial
preinitiation complex comprising B-TFIID that
primes the promoter for productive preinitiation
complex formation in mammalian cells.
INTRODUCTION
Accurate initiation of transcription by RNA polymerase
II (Pol II) requires the assembly of the multiprotein
preinitiation complex (PIC) on the core promoter around
the mRNA start site (1–3). Amongst the basal transcrip-
tion factors in this process is the TFIID complex com-
prising the TATA binding protein (TBP) and a set of
13–14 TBP-associated factors (TAFs) (4–7). Two add-
itional TBP-containing complexes involved in Pol II tran-
scription have been described, the B-TFIID complex,
where TBP is associated with BTAF1 and TAC, a
complex found in undifferentiated embryonic stem cells,
where TBP is associated with an unprocessed form of
basal transcription factor TFIIA (8). BTAF1 and its
yeast orthologue Mot1p belong to the SNF2 superfamily
of ATPases and they can dissociate TBP from DNA in an
ATP-dependent manner (9–12). While it was ﬁrst proposed
that Mot1p may be a transcriptional repressor, genome-
wide studies show that it is associated with active pro-
moters where it may use ATP hydrolysis to promote a
dynamic equilibrium of promoter occupancy between a
transcriptionally inactive Mot1p–TBP–NC2 complex and
an active TFIID complex (13–15).
The highly conserved TBP C-terminal core domain
binds DNA and interacts with basal transcription
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structure of TBP bound to TATA-containing DNA, as
well as with the basal transcription factors TFIIA,
TFIIB, NC2, BRF and the N-terminal domain of TAF1
have all been described (17–21). Surfaces involved in these
interactions have been mutated as part of a systematic
mutagenesis of all solvent-exposed residues (22–25). The
properties of the mutant TBPs have been evaluated in vitro
with respect to transcription using various Pol II and
Pol III promoters, binding to DNA, interaction with co-
factors and the ability to form higher-order DNA
complexes in vitro with its partners, and their ability to
support activated transcription in transfected mammalian
cells (22,26).
While previous studies provided considerable insight
into the structure–function relationships of TBP in mam-
malian cells, their scope has been limited to in vitro assays
or transfections with artiﬁcial promoters that may not re-
produce the complexity of the in vivo situation with the
diversity of promoters in mammalian cells. We have de-
veloped a unique approach to study TBP function in vivo
using mouse embryonic ﬁbroblasts (MEFs) where one
allele of the TBP gene has been inactivated and the
other has been ﬂoxed such that endogenous TBP can be
inactivated by Cre-recombinase. We have performed com-
plementation assays showing that TBP mutations affect-
ing critical interactions in vitro can complement loss of
endogenous TBP, but lead to impaired cell proliferation.
We identify TBP mutations which disrupt the TBP–
BTAF1 interaction and show that loss of B-TFIID
complex formation does not affect the global genomic dis-
tribution of TBP, but positively or negatively affects PIC
formation and Pol II recruitment at a selected set of
promoters.
MATERIALS AND METHODS
Isolation of the Tbp
lox/  MEFs
Mouse ES cells with a null allele of TBP (27) were re-
targeted with a second vector to introduce LoxP sites
around exon III of the Tbp gene. These ES cells were
used to generate mice with the corresponding genotype.
MEFs were derived from E10.5 embryos by standard pro-
cedures and immortalized using large T antigen from
SV40.
Generation and characterization of cells expressing
mutant TBPs
Tbp
lox/  MEFs were ﬁrst infected with pBABE retro-
viruses expressing WT or mutant N-terminal Flag-HA
tagged TBP. After puromycin selection, cell extracts
were prepared and expression of the exogenous TBP
veriﬁed by immunoblot. Cells were reinfected with a
second retrovirus vector expressing the tamoxifen indu-
cible Cre-ER
T2. After blasticidine selection, cells were
treated with hydroxy-tamoxifen (OHT) and clonal lines
established from limiting dilutions of cells. The deletion
of the Tbp alleles was veriﬁed ﬁrst by triplex poly-
merase chain reaction (PCR) genotyping and then
cell extracts were prepared from the selected cell clones
and TBP expression veriﬁed by immunoblot. Cell prolif-
eration analysis, Affymetrix microarrays, qPCR and
immunoblot were all performed by standard methods
as previously described (28). TBP was detected using
the 3G3 antibody that recognizes an epitope at the
extreme N-terminus shared between mouse and human
TBP (29).
Chromatin immunoprecipitation -sequencing
Chromatin immunoprecipitation (ChIP) and ChIP-seq ex-
periments were performed according to standard proto-
cols as previously described (30,31). Brieﬂy, ChIP-seq
was performed using an Illumina GAIIx sequencer and
the raw data analysed by the Illumina Eland pipeline
V1.6. Peak detection was performed using the MACS
software (http://liulab.dfci.harvard.edu/MACS/) (32)
under settings where the GFP ChIP was used as a
negative control. Peaks were then annotated using
GPAT [(33), http://bips.u-strasbg.fr/GPAT/Gpat_home
.html] using a window of  10kb with respect to the co-
ordinates of the beginning and end of RefSeq transcripts.
Global clustering analysis and quantitative comparisons
were performed using seqMINER [(34) (http://bips.u-
strasbg.fr/seqminer/]. Further details are provided in the
Supplementary Data. ChIP was performed with the fol-
lowing antibodies; TBP (Abcam, AB28175), Pol II,
MED6, XPB, TFIIB (Santa Cruz SC-9001, SC-9434,
C18-CS225, respectively), H3K4me3 (Upstate 07-473).
The TAF1 antibody was a kind gift from Dr. L. Tora.
Proteomics analysis
MEF cell nuclear extracts were prepared as previously
described and subjected to tandem Flag-HA afﬁnity
immunopuriﬁcation using Flag M2 beads, epitope peptide
elution followed by reprecipitation with HA-beads as pre-
viously described (35). The precipitated proteins were
digested with trypsin, and the tryptic peptides separated
by tandem strong cation exchange. Peptides were then
analysed by nanoﬂow-LC coupled to an LTQ-FTICR
mass spectrometer (Thermo Fisher Scientiﬁc). Spectra
were processed with Bioworks (version 3.1, Thermo
Fisher Scientiﬁc) and the subsequent data analysis was
carried out using Mascot (version 2.2.1, Matrix Science).
Mascot results ﬁles were ﬁltered to contain only pep-
tides above a Mascot ion score of 15 using in-house
written software. Scaffold (version 2.01.02, Proteome
Software) was used to validate protein identiﬁcations.
Protein identiﬁcations were accepted if they could be es-
tablished at >99.9% probability and contained at least
two identiﬁed peptides. Human TBP and its variants
were identiﬁed following essentially the same procedure,
but using a manually generated database containing
sequences of mouse TBP (Swiss-Prot accession number
P29037), human TBP (Swiss-Prot accession number
P20226), and those of the TBP mutants used in this
study. Further details are described in the Supplementary
Data.
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Mutations in TBP complementing loss of wild-type TBP
in mouse cells
Using homologous recombination, we generated ES cells
and mice harbouring a null allele in the Tbp gene by in-
sertion of a hygromycin resistance cassette in exon III and
a ﬂoxed allele, in which exon III is surrounded by LoxP
sites [(27) and see Supplementary Figure S1A]. From these
mice, we generated an embryonic ﬁbroblast Tbp
lox/  cell
line in which TBP expression can be inactivated by expres-
sion of the Cre recombinase leading to cell death (see
Supplementary Figure S1C and S1D). We adopted a
two-step strategy to generate Tbp
 /  cell lines expressing
human (h)TBP. Cells were ﬁrst infected with pBABE
retrovirus vectors expressing Wt hTBP or a series of mu-
tants in the TBP core region (Figure 1A), all of which
carry a Flag-HA tag on their N-terminus. Analysis of
infected cell populations revealed the presence of endogen-
ous mTBP and exogenous hTBP in most lines (Figure 1B,
lanes 2, 3 and 5), but for several mutants we were repro-
ducibly unable to observe stable expression of mutant
hTBP (lanes 1 and 4, summarized in Figure 1D). These
mutants comprise radical single amino acid substitu-
tions on the DNA binding surface of the ﬁrst repeat
(R203E and T210K), the H2 helix (R239E) or the TFIIB
interaction surface on the C-terminal stirrup (E286R,
Figure 1A).
Cells expressing endogenous mTBP and exogenous
hTBP were then infected with a second retrovirus express-
ing the four hydroxy-tamoxifen (OHT) inducible Cre-
ER
T2. Subsequently, multiple clonal populations from
the OHT treated cells were isolated and genotyped by
PCR to identify the Tbp
 /  clones (Supplementary
Figure S1B). At least two independent clones where ex-
pression of the endogenous mTBP was lost and replaced
by the exogenous hTBP were isolated (Figure 1C). Each
mutant hTBP was expressed at levels comparable, but not
identical to that of the endogenous mTBP in the Tbp
lox/ 
cells, with V162A, Q242A and R318A showing higher ex-
pression. These results indicate that all of these mutants
are capable of supporting cell viability, irrespective of
their previously characterized properties in vitro or in
transfection assays (see refs 22, 23 and 25) summarized
in Figure 1D). Although many mutant hTBPs can com-
plement loss of mTBP, the majority of cell lines display
a moderately or strongly reduced proliferation
(Supplementary Figure S2, summarized in Figure 1D).
The R186E mutation, on the other hand, led to increased
proliferation. At least two independent clones for each
mutant were analysed to ensure the reproducibility of
their phenotypes. Slow growth is particularly severe for
the L212A, K243E and R294A mutants. Analysis of
several mutant lines by ﬂuorescence-activated cell sorting
(FACS) analysis did not however reveal speciﬁc G1/S or
G2/M checkpoint arrest, rather a general lengthening of
all phases of the cycle. The slow growth seems to result
from defects in Pol II transcription as none of the muta-
tions had a signiﬁcant effect on Pol I and/or Pol III tran-
scription (Supplementary Figure S3).
TBP mutations that disrupt the B-TFIID complex
The properties of the hTBP mutants used here have been
previously evaluated in various in vitro assays for their
ability to interact with DNA, TFIIA, TFIIB, NC2 and
BTAF1 and/or for their ability to form ternary complexes
comprising TBP, DNA and one of the additional cofac-
tors [(22–25), summarized in Figure 1D]. We took advan-
tage of the N-terminal Flag-HA tag to perform tandem
afﬁnity puriﬁcation of Wt and mutant hTBPs from
nuclear extracts of the corresponding cell lines to address
how these mutations affect TBP interaction with its
partners. Mass spectrometry identiﬁed TBP and all
TFIID TAFs in puriﬁcations from cells expressing Wt
hTBP, but not in control puriﬁcations from untagged
Tbp
lox/  cells (Figure 2A and Supplementary Dataset S1
showing results of two independent experiments, Wt
hTBP and R188E with a negative control, and Wt
hTBP, a negative control and a series of mutants).
BTAF1, BRF and all four SL1/TIF1B subunits were
also present in Wt hTBP samples. Under the puriﬁcation
conditions used we did not detect any spectra for NC2 or
TFIIB, and only low numbers of spectra for TFIIA
(Supplementary Dataset S1). In these experiments, spectra
for more than 600 proteins were identiﬁed (Supplementary
Dataset S1). In addition to the known TAF partners, only
a small number of other proteins showed a pattern con-
sistent with a speciﬁc association with TBP, i.e. absent in
the control samples, but present in the Wt and in several
of the mutant samples (Supplementary Dataset S1).
Analysis of the mutant TBP samples showed that none
of the tested mutations signiﬁcantly affected interaction of
TBP with TFIID-TAFs. Several mutations appeared to
affect interaction with the SL1 subunits, in particular
TAFIC, but the number of recorded spectra for these
subunits is in general low and a signiﬁcant loss of this
interaction could not be conﬁrmed by immunoblotting
(Supplementary Figure S3B). In contrast, two mutations
(R188E and K243E) clearly resulted in a complete loss of
BTAF1 interaction. No spectra corresponding to this
protein were found in these samples, while abundant
spectra were observed with Wt hTBP (Figure 2A). Loss
of interaction was conﬁrmed by immunoblotting where
BTAF1 coprecipitates with Wt hTBP, but not with
R188E and K243E, whereas TAF4 and TAF6
coprecipitated with all three TBPs (Figure 2B). We also
noted signiﬁcantly reduced BTAF1 levels in nuclear ex-
tracts from the R188E and K243E cells not due to
changes in Btaf1 mRNA level, but more likely due to its
instability when not associated with TBP. Nevertheless,
we did not detect residual BTAF1 in the R188E and
K243E TBP immunoprecipitations. Amongst the partners
detected by mass spectrometry, these two mutations,
therefore, lead to a speciﬁc loss of interaction with
BTAF1 disrupting B-TFIID complex formation in mam-
malian cells. Their effect on other partners such as TFIIA
could not be assessed in this assay.
Further evidence for a role of the R188 and K243
residues for interaction with BTAF1 comes from examin-
ation of the structure of the Encephalitozoon Cuniculi
(Ec) TBP–BTAF1 complex that has been recently
1448 Nucleic Acids Research, 2012,Vol.40, No. 4Figure 1. Viability and proliferation properties of MEFs expressing mutant TBP. (A) Locations of the tested mutations on a two-dimensional
representation of the ternary structure of the TBP core domain. (B) Immunoblot analysis of endogenous mouse and exogenous human TBP in MEFs
infected with retroviruses expressing the TBP mutants shown above each lane. Endogenous mouse TAF4 is shown as loading control.
(C) Immunoblot analysis of cloned cell lines expressing the indicated exogenous hTBP mutants. The asterisk indicates that in some extracts the
Flag-HA tag has been cleaved from TBP during extract preparation. (D) Summary of cell lines expressing mutant TBPs, showing the mutated
amino acid, cell viability, cellular proliferation and interactions shown to be affected in in vitro assays (effects on TBP/DNA complex formation,
Pol II/Pol III transcription from an assayed promoter and on activation in transient expression assays). ND is not determined and DN is dominant
negative.
Nucleic Acids Research,2012, Vol.40, No. 4 1449resolved (36). The R188 and K243 residues are conserved
in EcTBP (R48 and K103, respectively, in Figure 3A) and
are at the interface (Figure 3B) where they make contacts
with residues in BTAF1 (Figure 3C and ref. 36). These
structural observations conﬁrm our present results and
previous in vitro biochemical studies on the essential role
of these TBP residues in B-TFIID complex formation.
Changes in gene expression in cells lacking B-TFIID
To determine the effect of loss of the TBP–BTAF1 inter-
action on gene expression, we performed a detailed
transcriptome analysis on two independently isolated Wt
hTBP and R188E mutant lines. Compared to MEFs ex-
pressing Wt hTBP, 274 and 200 genes were up- or
down-regulated 2-fold or more, respectively, in R188E
TBP MEFs (Supplementary Dataset S2) corresponding
to  4% of the total expressed genes. Amongst these, are
genes that are either strongly induced or repressed. The
mRNA proﬁling results were veriﬁed by RT-qPCR con-
ﬁrming that expression of R-spondin 2 (Rspo2), eyes
absent 4 homolog (Eya4) and SPARC related modular
calcium binding 2 (Smoc2) are up-regulated in the TBP
R188E cells, while plakophilin 2 (Pkp2) and coxsackie
Figure 2. Effects of TBP mutations on the interactions with partner proteins. (A) Mass spectrometry analysis showing the number of unique spectra
obtained for the each partner proteins after puriﬁcation of the indicated TBP mutant. C is a parallel control immunoprecipitation from non-tagged
cells. Two independent series of experiments are shown along with corresponding negative control. Spectra for TAF4 and TAF4b, TAF9 and TAF9b
are grouped together. Partner proteins are grouped by complexes. (B) Immunoblot analysis of TBP, BTAF1, TAF4 and TAF6 in immunoprecipitates
from cells expressing the indicated TBP mutants. (C) RT-qPCR analysis of mRNA expression. The relative expression levels of the indicated genes in
the cells expressing TBP R188E and K243E are shown.
1450 Nucleic Acids Research, 2012,Vol.40, No. 4virus and adenovirus receptor (Cxadr) were down-
regulated (Figure 2C). Rplp0, encoding an acidic riboso-
mal protein, was unchanged and is used as a control in
subsequent experiments (Figure 2C and see below). Thus,
the R188E mutation that destabilizes formation of the
B-TFIID complex does not have a general effect on tran-
scription, but rather positively or negatively affects expres-
sion of a selected set of genes.
Comparison of genome-wide occupancy of Wt and
R188E TBP
To determine whether loss of B-TFIID integrity affects
TBP promoter occupancy, we performed ChIP-seq experi-
ments on cells expressing Wt or R188E mutant TBPs.
ChIP was performed with antibodies against TBP, Pol II
and trimethylated lysine 4 of histone H3 (H3K4me3) and
Figure 3. Role of the R188 and K243 residues in TBP–BTAF1 interactions. (A) Alignment of human, yeast (S. cerevisiae) and the parasite
Encephalitozoon Cuniculi (Ec) TBPs showing the conservation of the R188 and K243 residues (asterisks). (B) Ribbon representation of the structure
of EcTBP and BTAF1 (Mot1p). The side chains of EcTBP R48 and K103 are indicated. (C) The contacts made between EcTBP R48 and K103 and
the EcBTAF1 residues are summarized. Figure adapted from ref. (36).
Nucleic Acids Research,2012, Vol.40, No. 4 1451the ChIPed DNA analysed by Illumina sequencing. Peak
detection (‘Materials and Methods’ section and
Supplementary Data), identiﬁed  13000 binding sites
for Wt TBP in the genome. The majority of these are
located at the transcription start sites (TSS) of annotated
genes, although TBP binding sites can also be found in
intergenic regions with or without associated Pol II
(Supplementary Figure S4A and S4B). The speciﬁcity of
the ChIPs was veriﬁed by ChIP-seq with an anti-GFP
antibody and by independent ChIP-qPCR experiments
(Supplementary Figure S5A). Analysis of the sequences
at the TBP occupied sites showed that around 5% con-
tained the 50-TATAW-30 consensus for TBP binding. This
is similar to the general frequency of TATA elements in
Pol II promoters (37). Moreover, this sequence is not
enriched in the 1000 most occupied sites indicating that
TATA-containing promoters do not show higher than
average TBP occupancy (Supplementary Figure S5B).
At the control TATA-containing Rplp0 promoter com-
parable TBP occupancy can be seen in the Wt and
R188E-expressing cells along with Pol II occupancy at
the promoter and transcribed regions and H3K4me3 at
the 50 region (Figure 4A). Analogous proﬁles for Wt
TBP, Pol II and H3K4me3 are seen at the majority of
expressed genes (Supplementary Figure S5C). A global
comparison of the ChIP-seq data for each cell type by
read density clustering analysis shows that TBP and Pol
II are present at approximately 10000 RefSeq start sites
corresponding to the different classes of expressed genes
(Figure 4B). In addition, there is no gross quantitative
re-distribution of TBP at the TSS in cells expressing the
hTBP R188E mutation (Supplementary Figure S5C), con-
sistent with the observation of only a small number of
genes showing altered expression. Thus, loss of B-TFIID
complex formation does not result in a global redistribu-
tion of TBP at TSS. Nevertheless, comparison of TBP Wt
and R188E occupied loci revealed a group of more than
4000 sites that appeared enriched in the R188E expressing
cells (Supplementary Figure S6A). Further re-clustering of
this group identiﬁed 1334 loci that are enriched in the
R188E cells and 397 loci that display a low occupancy
of R188E TBP, but show no signiﬁcant signal for Wt
TBP. This is conﬁrmed by a quantitative comparison
showing that these later sites are weakly occupied by
TBP R188E, but show no signiﬁcant occupancy by Wt
TBP (Supplementary Figure S6B). The vast majority of
these sites are located in intergenic and intragenic
regions, rather than at the TSS of annotated genes.
Differential Pol II recruitment at R188E TBP-regulated
genes
To understand the molecular basis underlying the changes
in gene expression in the R188E TBP cells, we more
closely examined TBP and Pol II occupancy at the loci
of 172 most differentially regulated genes. A quantitative
comparison of the up-regulated genes indicated a correl-
ation with an increased Pol II occupancy, while changes in
TBP occupancy are in general less marked (Figure 4C).
This suggests that Wt TBP is present at these promoters
without a subsequent recruitment of Pol II. For example,
at the Rspo2 promoter in Wt TBP cells, both H3K4
trimethylation and TBP occupancy can be clearly ob-
served, but Pol II is absent (Figure 5A). In the R188E-
expressing cells, increased signals for TBP and H3K4me3
are observed, but Pol II is now strongly recruited to the
promoter. These observations were conﬁrmed in inde-
pendent ChIP-qPCR experiments showing the presence
of a basal level of Wt TBP that is increased with R188E
TBP, whereas Pol II is recruited only by TBP R188E
(Figure 5B). A similar situation was seen at the Eya4
promoter where Pol II is observed only in the R188E
TBP cells (Figure 5C and D).
One interpretation of these observations is that, while
TFIID containing Wt TBP can initiate PIC formation,
only TFIID containing R188E TBP is capable of recruit-
ing Pol II to the Rspo2 and Eya4 promoters. Alternatively,
it is possible that Wt TBP occupies these promoters in the
B-TFIID complex, while in the R188E-expressing cells
they are occupied by TBP present in TFIID.
ChIP-qPCR experiments detected TFIIB and MED6 oc-
cupancy at both promoters in the Wt and R188E TBP
cells showing that PIC formation had been initiated in
each case (Figure 5B and D), while TFIIE is seen only
in the R188E TBP cells. In contrast, BTAF1 is detected
at the Rspo2 and Eya4 promoters in the Wt, but not in the
R188E mutant cells, whereas the TFIID-speciﬁc TAF1 is
recruited only in the TBP R188E cells. Similar results were
seen for each of these factors in cells expressing the K243E
mutation (Figure 5B and D), which also affects B-TFIID
formation and expression of Rspo2 and Eya4 is strongly
activated in these cells (Figure 2C).
As the R188E and K243E mutations have also been
reported to affect interaction with TFIIA (22,23,25), we
asked if TFIIA could be differentially recruited to the
Rspo2 and Eya4 promoters. Anti-TFIIA ChIP readily
detected TFIIA at the Rplp0 promoter in both Wt and
mutant TBP expressing cells (Supplementary Figure
S5A), but no signiﬁcant signal for TFIIA could be seen
at the Rspo2 and Eya4 promoters in any cell type (data not
shown). Thus, TFIIA does not seem to be recruited to
these promoters, whereas the transcriptional effects that
are seen correlate with differential B-TFIID and TFIID
recruitment.
To further show that TFIIB and BTAF1 or TAF1
co-occupy the above promoters, we performed a TFIIB
ChIP and then reChIPed the eluate with either BTAF1 or
TAF1 antibodies (Figure 6A). Co-occupancy of TFIIB
and TAF1, but not BTAF1, was seen at the Rplp0
promoter in TBP Wt and R188E and K243E mutant
cells (Figure 6B). In contrast, TFIIB–BTAF1 co-
occupancy was seen at the Eya4 and Rspo2 promoters in
TBP Wt cells, whereas TFIIB–TAF1 co-occupancy was
seen in the TBP R188E and K243E expressing cells. No
signiﬁcant signal was seen with any combination at the
control Tnp1 promoter.
The combination of ChIP-seq, ChIP-qPCR and ChIP-
reChIP show that, in cells expressing Wt TBP, B-TFIID
initiates formation of an incomplete PIC comprising
TFIIB and the Med complex, but not TFIIE, whereas in
cells expressing mutant TBPs not competent to interact
with BTAF1, TFIID replaces B-TFIID allowing
1452 Nucleic Acids Research, 2012,Vol.40, No. 4Figure 4. Genome-wide distribution of TBP in Wt and R188E expressing cells. (A) Screen shots of .Wig ﬁles of the TBP, Pol II and H3K4me3
ChIP-seq from cells expressing Wt and R188E TBPs at the Rplp0 locus. (B) Comparative clustering of ChIP-seq data at the 23630 RefSeq TSS in Wt
and R188E TBP cells. Tag densities from each ChIP-seq dataset were collected in a window of 10kb around the TSS. The collected values were
subjected to k-means clustering coupled to ranked based-normalization. This clustering identiﬁes distinct classes: (A and B) Highly transcribed
anti-sense and sense, (C and D), moderately transcribed anti-sense and sense, (E) no occupancy and not transcribed. (C and D) Differential
occupancy at the promoters of de-regulated genes. Quantitative analysis of TBP, Pol II and H3K4me3 at the promoters of (C) genes up-regulated
and (D) down-regulated in R188E TBP cells.
Nucleic Acids Research,2012, Vol.40, No. 4 1453Figure 5. Binding of PIC components at the promoters of up-regulated genes. (A and C) UCSC screen shots of TBP, Pol II and H3K4me3 ChIP-seq
results at the Rspo2 and Eya4 loci, respectively. (B and D) ChIP-qPCR with the indicated antibodies in the Wt, R188E and K243E cells at the Rspo2
and Eya4 promoters using the haploid cell-speciﬁc transition protein 1 (Tpn1) promoter as negative control.
1454 Nucleic Acids Research, 2012,Vol.40, No. 4recruitment of TFIIE along with Pol II to activate Rspo2
and Eya4 expression.
At genes showing down-regulation, there is a strong
reduction in both TBP and Pol II occupancy, while
H3K4me3 is less affected (Figure 7A and B and a more
global comparison in Figure 4D). Examples of this are
seen at the plakophilin 2 (Pkp2) or coxsackie virus and
adenovirus receptor (Cxadr). At both promoters, the TBP,
Pol II, TFIIB and MED6 levels present in Wt cells are
almost completely lost in the R188E and K243E TBP
cells, but signiﬁcant residual H3K4me3 levels persist
(Figure 7A and B and data not shown). Interestingly,
however, differential recruitment of Wt and mutant TBP
does not always lead to changes in gene expression. For
example, R188E TBP is strongly and selectively recruited
to the promoter of the divergent potassium voltage-gated
channel, shaker-related subfamily, beta member 2
(Kcnab2) and nephronophthisis 4 (Nphp4) genes, but
there is no recruitment of Pol II and no expression of
these genes (Supplementary Figure S7).
Taken together, our data show that TBP recruitment
does not necessarily lead to gene activation and reveal the
existence of a set of promoters where TBP in the form of
B-TFIID assembles a partial PIC that maintains them in a
non-productive state, but primes them for activation.
DISCUSSION
Genome-wide studies of TBP function and distribution
have previously been mainly performed in yeast (14,38).
In this study, we analysed mammalian TBP function in an
experimental system allowing substitution of Wt TBP by
mutated variants identifying two mutants exclusively af-
fected in B-TFIID formation. Comparative genome-wide
occupancy analysis of the wild-type and mutant cells
identiﬁes a novel primed promoter state at a subset of
genes in mammalian cells.
TBP surfaces required for function in mammalian cells
We have investigated the ability of hTBPs bearing single
amino acid substitutions to complement lethality upon
loss of endogenous mTBP. Several mutant TBPs could
not be expressed even in cells harbouring endogenous
TBP probably reﬂecting a dominant negative activity of
these mutants. Mutation R203E has been shown to affect
interaction with DNA (22,23) and TFIIA (22), while
T210K is a radical mutation in the ﬁrst half of the
DNA-binding surface. These mutant TBPs interact nor-
mally with the TAF partners, but they cannot bind
TATA-containing promoter DNA explaining their domin-
ant negative behaviour. E286R is a radical mutation in the
TFIIB interaction surface (22). This mutant interacts with
TAFs and binds promoter DNA, but fails to interact with
TFIIB showing that TBP–TFIIB interaction is essential
for viability of mammalian cells. The basis of the dominant
negative effect of the R239A mutation on the H2 helix
remains to be determined.
Mutations that strongly compromise speciﬁc TBP inter-
actions or activated transcription in transfected cells are
nevertheless capable of complementation. V162A, R188E,
L212A and K249A. V162A have been shown to prevent
formation of the TBP–TFIIB–DNA complex in vitro (23).
R188E affects formation of the TBP–NC2–DNA
complex, strongly reduces in vitro transcription from the
U1 and U6 promoters by Pol II and Pol III, respectively
(25),affectsinteractionwithTFIIAandabolishesactivated
transcription (22,26). L212A strongly down-regulates U6
transcription by Pol III in vitro (25), while K249A
Figure 6. Exchange of B-TFIID for TFIID at the Eya4 and Rspo2 promoters. (A) Schematic description of the ChIP-reChip strategy. (B) Results of
ChIP-reChip-qPCR experiments showing the presence of a TFIIB–BTAF1 complex at the Eya4 and Rspo2 in TBP Wt cells and a TFIIB–TAF1
complex at these promoters in the TBP R188E and K243E cells.
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complexes (23). Despite the effects of these mutants
in vitro, they support MEF cell viability. Thus, while
mutations may affect a speciﬁc interaction in vitro,i n
the context of the living cell additional interactions
with modiﬁed histones (39,40) and/or the presence of
TAFs may stabilize the PIC and overcome weakened
interactions of TBP with DNA or its protein partners.
Interaction of TBP with BTAF1 plays a limited, but
speciﬁc role in transcription regulation
Viable TBP mutants associate normally with the TFIID-
and SL1-TAFs as well as with BRF1 of TFIIIB. Under
the same conditions, however, mutations R188E and
K243E selectively disrupt the TBP–BTAF1 interaction
and hence formation of B-TFIID. These mutations were
previously shown to affect TBP–BTAF1 interactions
in vitro (23). The R188E mutation had a milder effect
in vitro than other mutations, such as V162A, or R186E
that do not affect B-TFIID integrity in cells. In vitro
assembly of B-TFIID from recombinant TBP and
BTAF1 has therefore different requirements from the
regulated assembly in living cells. The role of the R188E
and K243E residues in TBP–BTAF1 interactions has
recently been conﬁrmed by the resolution of the structure
of the TBP–BTAF1 complex from Encephalitozoon
Cuniculi (36). These two residues lie at the interface
Figure 7. Loss of TBP and Pol II recruitment at down-regulated genes. (A) UCSC screen shot of TBP, Pol II and H3K4me3 ChIP-seq data at the
Pkp2 locus. (B) ChIP-qPCR with the indicated antibodies in the Wt, R188E and K243E cells and these promoters using the Tpn1 promoter as
negative control.
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interaction.
Gene expression proﬁling shows no general effect on
transcription by Pol II upon loss of B-TFIID, but the
R188E and K243E mutations selectively affect expression
of a subset of genes. In agreement with the speciﬁc effects
on gene expression, loss of B-TFIID does not result in a
global change in TBP occupancy. A subset of mostly inter-
and intra-genic loci showed higher occupancy in the
R188E expressing cells in agreement with previous pro-
posals that Mot1p can remove TBP from non-promoter
sites mobilizing it for use at promoters (41,42).
The R188E and K243E mutations may also affect inter-
actions with other cofactors such as TFIIA. We were
unable to determine the effects of these mutations on
TBP–TFIIA and TBP–NC2 interactions by mass spec-
trometry as these proteins did not purify with TBP
under the conditions used. Nevertheless, while these mu-
tations have been reported to affect interaction with TBP
in vitro (22,23,25), they did not alter TFIIA occupancy at
the Rplp0 promoter in cells and we did not see signiﬁcant
TFIIA occupancy at the Rspo2 and Eya4 promoters in
TBP Wt or mutant cells. Hence, at promoters where we
observe TFIIA, we do not see BTAF1 and vice versa in
agreement with the fact that TBP–TFIIA and TBP–
BTAF1 interactions are mutually exclusive (36). These ob-
servations suggest that the transcriptional effects seen at
these promoters are principally due to differential recruit-
ment of B-TFIID and TFIID and not of TFIIA.
The effects seen upon loss of TBP–BTAF1 interaction
differ from those seen upon knockdown of BTAF1 expres-
sion which has been shown to lower TBP mobility in the
nucleus (43). In human cells, BTAF1 knockdown was
shown to increase TBP occupancy at several promoters
(43) and maybe also more globally in the genome (44).
However, although we observed reduced BTAF1 levels
in the R188E and K243E mutant cells, we did not
observe increased TBP promoter occupancy. As our
experiments were performed in MEFs, while the
knockdown experiments were performed in U2OS and
HeLa cells, it possible that loss of BTAF1 does not have
the same effects in all mammalian cell types.
Evidence for a novel primed promoter state controlling
productive PIC formation in vivo
Analysis of genes up-regulated in cells expressing mutant
TBPs showed that Wt TBP and BTAF1 are present at
their promoters, but assemble an incomplete PIC lacking
TFIIE and Pol II. In contrast, in the R188E and K243E
cells, TFIIE and Pol II are recruited and they are
transcribed into stable mRNA. Importantly, the TFIID
subunit TAF1 is recruited to these promoters only in the
R188E and K243E mutant cells, while BTAF1 is lost. Wt
TBP is therefore recruited to these promoters in the form
of B-TFIID that nucleates formation of a partial PIC,
whereas R188E and K243E TBP are recruited as TFIID
that is competent to form a full PIC, recruit Pol II and
initiate transcription.
In contrast to the above, we also identify genes that are
down-regulated by the R188E and K243E mutations. At
many of these loci, we observe a total or partial loss of
TBP and Pol II, but not a complete inactivation as
H3K4me3 persists at these loci. These observations
suggest that the TBP–BTAF1 interaction is required for
normal TBP recruitment and PIC formation at these loci.
Only a small number of cellular promoters show differ-
ential positive and negative regulation in the R188E cells
and we have not been able to determine common charac-
teristics (for example, consistent presence or absence of a
TATA or other promoter elements) that would confer this
type of regulation. Similarly, gene ontology analysis did
not reveal obvious related functions (like cell-cycle pro-
gression) for the deregulated genes.
Together, our data demonstrate that the formation of a
stable B-TFIID complex is not essential for cell viability
Figure 8. Cartoons illustrating models for the differential effect of mutations in TBP on PIC recruitment and gene expression. Genes may be
activated by promoting exchange of B-TFIID for TFIID. In contrast, at other promoters the same TBP mutations can lead to a loss in TBP
occupancy and gene expression.
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transcriptional programme. Our genome-wide occupancy
analysis of Wt and R188E mutant TBP and the activating
H3K4me3 histone modiﬁcation indicates that certain
mammalian promoters are occupied by transcriptionally
inactive forms of TBP. At a subset of promoters, B-TFIID
assembles a partial and transcriptionally inactive PIC. The
inactivity of these promoters is not due to high levels of
NC2 binding as, while we detect NC2 occupancy at pro-
moters such as the Rplp0 control, it is below the level of
detection at the repressed promoters (our unpublished
data). This deﬁnes a new mechanism controlling mRNA
synthesis involving ‘stalled preinitiation complex
assembly’ (Figure 8). This is reminiscent of the mechanism
whereby full PIC formation takes place, but Pol II remains
in a paused state downstream of the TSS to repress pro-
ductive mRNA synthesis (1). This, together with our
study, shows that transcription can be regulated at
several steps through formation of a partial PIC lacking
Pol II or following complete PIC formation by pausing of
Pol II at the promoter.
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